Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

BIO-key faces Nasdaq compliance issue over late filings

EditorBrando Bricchi
Published 05/25/2024, 05:04 AM
© Reuters.
BKYI
-

WALL, N.J. - BIO-key International, Inc. (NASDAQ:BKYI), a provider of identity and access management solutions, disclosed it has received a notification from Nasdaq regarding non-compliance with filing requirements. The Nasdaq Listing Rule 5250(c)(1) mandates timely submission of periodic financial reports to the Securities and Exchange Commission (SEC), which BIO-key has failed to meet for its quarterly report for the period ending March 31, 2024.

The company had previously submitted a Notification of Late Filing on May 16, 2024, due to delays in restating its financial statements for several periods in 2023. This restatement process has affected the completion and review of financial disclosures needed for the latest quarterly report.

Despite the delay, the notification does not immediately impact the trading of BIO-key's common stock on the Nasdaq Capital Market. However, the company must submit a plan to regain compliance by June 17, 2024. If the plan is accepted, Nasdaq may allow an extension up to October 14, 2024, for BIO-key to file the delinquent reports and adhere to listing requirements.

BIO-key's management has expressed its intention to file the outstanding Form 10-Q and the annual Form 10-K as soon as feasible and is focused on regaining compliance with Nasdaq's continued listing standards.

The company specializes in biometric-centric, multi-factor identity and access management software, serving over forty million users. Its solutions, which include the PortalGuard IAM solution, aim to provide secure and convenient access across various platforms.

The information in this article is based on a press release statement from BIO-key International, Inc. and does not include any speculative content or opinions.

InvestingPro Insights

BIO-key International, Inc. (NASDAQ:BKYI) is navigating challenging financial waters, as reflected in the company's recent non-compliance notification from Nasdaq. The InvestingPro platform provides a deeper look into the company's financial health and market performance, offering valuable insights for investors considering BIO-key's stock.

An analysis of real-time data from InvestingPro shows that BIO-key operates with a market capitalization of just $3.48 million, a relatively small size which could impact its market liquidity and volatility. The company's revenue has experienced a significant growth of 38.59% over the last twelve months as of Q1 2023, indicating some operational progress despite the compliance issues. However, the company's struggle is evident in its negative price-to-earnings (P/E) ratio of -0.41, which suggests that investors are not expecting earnings growth in the near future.

InvestingPro Tips highlight several concerns for BIO-key, including its significant debt burden and the analysts' consensus that the company will not be profitable this year. The company's stock price performance also raises flags, having fallen significantly over the last year and taken a big hit over the last six months, with a 1 Year Price Total Return of -87.76%.

For investors seeking additional insights, there are 11 more InvestingPro Tips available for BIO-key International, Inc. at InvestingPro. These tips could provide further clarity on the company's financial position and market prospects. To access these and other valuable investment tools, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.